Milne Diane, Kampanis Petros, Nicol Samantha, Dias Sylvia, Campbell David G, Fuller-Pace Frances, Meek David
Molecular Signaling Group, Biomedical Research Centre, University of Dundee, Dundee DD1 9SY, UK.
FEBS Lett. 2004 Nov 5;577(1-2):270-6. doi: 10.1016/j.febslet.2004.09.081.
MDM2 is an E3 ubiquitin ligase which mediates ubiquitylation and proteasome-dependent degradation of the p53 tumor suppressor protein. Phosphorylation of MDM2 by the protein kinase AKT is thought to regulate MDM2 function in response to survival signals, but there has been uncertainty concerning the identity of the sites phosphorylated by AKT. In the present study, we identify Ser-166, a site previously reported as an AKT target, and Ser-188, a novel site which is the major site of phosphorylation of MDM2 by AKT in vitro. Analysis of MDM2 in cultured cells confirms that Ser-166 and Ser-188 are phosphorylated by AKT in a physiological context.
MDM2是一种E3泛素连接酶,可介导p53肿瘤抑制蛋白的泛素化和蛋白酶体依赖性降解。蛋白激酶AKT对MDM2的磷酸化被认为可响应生存信号调节MDM2的功能,但AKT磷酸化位点的身份一直存在不确定性。在本研究中,我们鉴定出Ser-166(一个先前报道为AKT作用靶点的位点)和Ser-188(一个新位点,是体外MDM2被AKT磷酸化的主要位点)。对培养细胞中MDM2的分析证实,在生理条件下Ser-166和Ser-188会被AKT磷酸化。